IL22 and type 1 diabetes mellitus: In Type 1 Diabetes (T1D), a reduction in IL-17 and IL-22 production by MAIT cells leads to compromised mucosal barrier integrity and increased intestinal permeability (23, 63–65, 89, 91–93).